Policymakers and Payers

This report, produced in collaboration with the Partnership to End Addiction, analyzes requirements for health plans to use specific criteria and assessment tools to determine medical necessity for substance use disorders.

The aim of the Lexicon is to describe the functions which define integrated behavioral health in primary care practices to clarify what to implement and what to expect.

This Topic Brief discusses perinatal behavioral health conditions, which include mental health and substance use disorders during pregnancy and the postpartum period (up to 12 months after delivery).

This brief assesses whether and how rates of substance use and substance use disorder among adults differ by race and ethnicity using five years of data, 2015-2019, from the National Survey on Drug Use and Health.

This publication is intended to aid policymakers, communities, and key stakeholders in developing comprehensive, multi-system strategies that address the opioid crisis.

This SAMHSA Advisory outlines the principles and components of low barrier care and how low barrier care may be leveraged to overcome substantial gaps in access, while also engaging individuals in treatment.

This public meeting explored real-world experiences and scientific evidence on emerging data trends for human xylazine exposure and examined concrete strategies for drug development and clinical research.

This issue brief provides federal and state policymakers with ways they can support low-threshold buprenorphine prescribing through reimbursement policies, treatment guidelines, and regulations.

This report, produced in collaboration with the Partnership to End Addiction, analyzes standards of prior authorization requirements in both public and private insurance plans.

The Pew Charitable Trusts